--- title: "The pan-European STOXX 600 index closed up nearly 1%, with Novo Nordisk rising over 4%" type: "News" locale: "en" url: "https://longbridge.com/en/news/267399052.md" description: "European stock markets closed slightly higher on Monday, with the pan-European STOXX 600 index rising by 0.9%. Novo Nordisk's stock price increased by over 4% due to the results of a weight loss drug trial. The UK's FTSE 100 index rose by 0.8%, Germany's DAX index increased by 1%, and France's CAC40 index climbed by 0.8%" datetime: "2025-11-25T17:47:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/267399052.md) - [en](https://longbridge.com/en/news/267399052.md) - [zh-HK](https://longbridge.com/zh-HK/news/267399052.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/267399052.md) | [繁體中文](https://longbridge.com/zh-HK/news/267399052.md) # The pan-European STOXX 600 index closed up nearly 1%, with Novo Nordisk rising over 4% Market expectations for a rate cut by the Federal Reserve in December have resurfaced, with European stocks closing slightly higher on Monday, as the pan-European STOXX 600 index rose by 0.9%. Danish pharmaceutical company Novo Nordisk announced positive results from the mid-term trials of its new generation weight loss drug Amycretin, with its stock price rising over 4%. The UK FTSE 100 index closed up 74 points or 0.8%, at 9,609 points. The German DAX index closed up 225 points or 1%, at 23,464 points. The French CAC40 index closed up 66 points or 0.8%, at 8,025 points ### Related Stocks - [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md) ## Related News & Research - [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/en/news/281206892.md) - [Novo Nordisk A/S Approves Final Dividend for 2025, Payable in March 2026](https://longbridge.com/en/news/280694679.md) - [Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program](https://longbridge.com/en/news/280885256.md) - [UK Regulator Recommends Novo Nordisk's Wegovy for People at Risk of Heart Attacks, Strokes](https://longbridge.com/en/news/281294814.md) - [](https://longbridge.com/en/news/281216333.md)